These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19395875)

  • 1. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
    Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
    Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM17 promotes glioma cell malignant phenotype.
    Zheng X; Jiang F; Katakowski M; Lu Y; Chopp M
    Mol Carcinog; 2012 Feb; 51(2):150-64. PubMed ID: 21480393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
    Zheng X; Jiang F; Katakowski M; Kalkanis SN; Hong X; Zhang X; Zhang ZG; Yang H; Chopp M
    Cancer Sci; 2007 May; 98(5):674-84. PubMed ID: 17355261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Meng X; Hu B; Hossain MM; Chen G; Sun Y; Zhang X
    Int J Oncol; 2016 Aug; 49(2):682-90. PubMed ID: 27221510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
    Wang XJ; Feng CW; Li M
    Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
    Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
    Nat Commun; 2011; 2():229. PubMed ID: 21407195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.
    Lin P; Sun X; Feng T; Zou H; Jiang Y; Liu Z; Zhao D; Yu X
    Mol Cell Biochem; 2012 Jan; 359(1-2):235-43. PubMed ID: 21837402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.
    Gramling MW; Beaulieu LM; Church FC
    Exp Cell Res; 2010 Feb; 316(3):314-28. PubMed ID: 19891966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
    Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
    Maretzky T; Zhou W; Huang XY; Blobel CP
    Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
    Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
    Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
    Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
    J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
    Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.